The general goals of Fimea's research activities include promoting the wellbeing of the population, improving public health, optimising health care costs with rational use of medicines, and contributing to decision-making in society. According to Fimea's strategy, research activities are based on the Act on the Finnish Medicines Agency and on the Research Strategy for Rational Pharmacotherapy and the Pharmaceutical Policy 2020 statement of the Ministry of Social Affairs and Health. Under law, Fimea's research areas are pharmacoepidemiology, pharmacoeconomy and pharmaceutical policy. Additionally, Fimea is tasked with building collaboration in these research areas.